Automated description from the Alliance of Genome Resources
Predicted to have carbonyl reductase (NADPH) activity and oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor. Predicted to be involved in drug metabolic process; oxidation-reduction process; and vitamin K metabolic process. Predicted to localize to the microvillus; nucleus; and plasma membrane. Is expressed in several structures, including alimentary system; cardiovascular system; genitourinary system; nervous system; and sensory organ. Orthologous to human CBR1 (carbonyl reductase 1).